Leveraged Finance Fights Melanoma
2018 Leveraged Finance Fights Melanoma Event
MRA held the seventh annual Leveraged Finance Fights Melanoma at the Rockefeller Center in New York City on Wednesday, May 23 from 6:00 to 9:00 PM.
The 2018 event was chaired by
Brendan Dillon (UBS), Lee Grinberg (Elliott Management),
George Mueller (KKR), AJ Murphy (BAML)
Geoff Oltmans (Silver Lake), Jeff Rowbottom (PSP Investments),
Cade Thompson (KKR), & Trevor Watt (Hellman & Friedman)
Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities who come together to fight melanoma, the deadliest form of skin cancer. Some of the most prominent names in the industry —Carl Icahn, Mike Milken, Leon Black, Henry Kravis and Howard Marks—have been featured.
The annual event raises critical funds for melanoma research and awareness on skin cancer prevention. Founded in 2011 by Jeffrey Rowbottom of PSP Investments and Brendan Dillon of UBS—both of whom combatted melanoma— the LFFM event has raised more than $8.6 million that goes directly to research.
Advances in melanoma research supported by MRA have changed the landscape dramatically for patients, with 11 of the 13 treatment options coming to market since the event’s kick-off. These advances have created a ripple effect across the field of oncology. Drugs first approved in melanoma are now being tested in more than 30 cancers.